33P Enhancing expert access and harmonising care pathways in rare gynaecological tumours across Europe: Real-world outcomes from the EURACAN G2 transnational virtual MDT 2023-2025

Gloria Marquina; A. Bergamini; Ulrika Joneborg; C. Lok; N. Van Trommel; CM Sassu; O. Solheim; M. Bini; C. Lebreton; P. Pautier; Matthew Winter; Grzegorz Szewczyk; A. Auranen; S. Aust; M.P. Kubelac; H. Denys; A. Casado Herráez; MJ Seckl; I. Ray-Coquard

doi:10.1016/j.esmorc.2026.100240

33P Enhancing expert access and harmonising care pathways in rare gynaecological tumours across Europe: Real-world outcomes from the EURACAN G2 transnational virtual MDT 2023-2025

Gloria Marquina(Hospital Clínico San Carlos), A. Bergamini(IRCCS Ospedale San Raffaele), Ulrika Joneborg(Karolinska University Hospital), C. Lok(The Netherlands Cancer Institute), N. Van Trommel(Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital), CM Sassu(Agostino Gemelli University Polyclinic), O. Solheim(Oslo University Hospital), M. Bini(Fondazione IRCCS Istituto Nazionale dei Tumori), C. Lebreton(Institut Bergonié), P. Pautier(Institut Gustave Roussy), Matthew Winter(Weston Park Cancer Centre), Grzegorz Szewczyk(Medical University of Warsaw), A. Auranen(Tampere University Hospital), S. Aust(Medical University of Vienna), M.P. Kubelac(Institute of Oncology Prof. Dr. Ion Chiricuta), H. Denys(Ghent University Hospital), A. Casado Herráez(Hospital Clínico San Carlos), MJ Seckl(Imperial College Healthcare NHS Trust), I. Ray-Coquard(Centre Léon Bérard)

ESMO rare cancers.

March 1, 2026

10.1016/j.esmorc.2026.100240

Cited by 0

Abstract

Related Papers

No related papers found

Powered by citation graph analysis